Summary
- Current Price
- As of today, SCTX price is $20.77, up +8.63% on
- Current Price All-Time High
- SCTX price is currently -47.55% below its historical high of $39.60 set on
- Market Cap
- SCTX current market cap is $393M
- Revenue
- SCTX current annual revenue is $51.17M, up +86.68% year-over-year
- Next Earnings
- The next earnings release for SCTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Scribe Therapeutics Inc. |
| Ticker | NASDAQ: SCTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | scribetx.com |
| Employees | 89 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $20.77 | |
| Price, 1D Change | +8.63% | |
| $393M | ||
| - | ||
| - | ||
| -0.93 | ||
| $51.17M | ||
| Revenue, 1Y Change | +86.68% | |
| -$1.24 | ||
| EPS, 1Y Change | +54.36% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.24 | ||
| EPS Estimate | - | |
| EPS Est. Change | - | |
| $51.17M | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $20.77 | |
| Price Target | $59.00 | - |
| Price Tgt. Change | +184.06% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$2.72 | - | |
| - | -$1.24 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $27.41M | - | |
| - | $51.17M | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $20.77 | |
| $25.00 | ||
| $25.81 | ||
| - | ||
| $24.08 | ||
| -$1.98 | ||
| -0.93 | ||
| $3.11 | ||
| 45.74 | ||
| 109.34% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $51.17M | ||
| -$1.24 | ||
| $0.00 | ||
| 93.99% | ||
| -$22.49M | ||
| -43.95% | ||
| -$21.81M | ||
| -42.62% | ||
| -$19.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -1.80 | ||
| 0.97 | ||
| 0.97 | ||
| - | ||
| - | ||
| 0.14 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 94.73 | ||
| -2.39 | ||
| -19.42 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$143.42M | ||
| $57.96M | ||
| $80.40M | ||
| $66.93M | ||
| $103.46M | ||
| $69.06M | ||
| $41.43M | ||
| $36.62M | ||
| $4.57M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $72.98M | ||
| $70.59M | ||
| $3.08M | ||
| $0.00 | ||
| $3.08M | ||
| $0.00 | ||
| -$1.80M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$45.21M | ||
| $45.27M | ||
| $142.00K | ||
| $1.27M | ||
| -$46.48M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Wells Fargo | ||
| Leerink Partners | ||
| Guggenheim |
Analyst sentiment
Institutional ownership
No data
Screeners with SCTX
FAQ
- What is the ticker symbol for Scribe Therapeutics Inc.?
- The ticker symbol for Scribe Therapeutics Inc. is NASDAQ:SCTX
- Does Scribe Therapeutics Inc. pay dividends?
- No, Scribe Therapeutics Inc. does not pay dividends
- What sector is Scribe Therapeutics Inc. in?
- Scribe Therapeutics Inc. is in the Healthcare sector
- What industry is Scribe Therapeutics Inc. in?
- Scribe Therapeutics Inc. is in the Biotechnology industry
- What country is Scribe Therapeutics Inc. based in?
- Scribe Therapeutics Inc. is headquartered in United States
- When did Scribe Therapeutics Inc. go public?
- Scribe Therapeutics Inc. initial public offering (IPO) was on July 24, 2026
- Is Scribe Therapeutics Inc. in the S&P 500?
- No, Scribe Therapeutics Inc. is not included in the S&P 500 index
- Is Scribe Therapeutics Inc. in the NASDAQ 100?
- No, Scribe Therapeutics Inc. is not included in the NASDAQ 100 index
- Is Scribe Therapeutics Inc. in the Dow Jones?
- No, Scribe Therapeutics Inc. is not included in the Dow Jones index
- When does Scribe Therapeutics Inc. report earnings?
- The next expected earnings date for Scribe Therapeutics Inc. is November 11, 2026
Data Sources & References
- SCTX Official Website www.scribetx.com
- SCTX Profile on Yahoo Finance finance.yahoo.com/quote/SCTX
- SCTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sctx